Results 151 to 160 of about 1,816 (199)

A retrospective study reporting the incidence, risk factors, and intraocular pressure rise in patients receiving intravitreal steroids for retinal inflammatory diseases in a tertiary eye care hospital of South India. [PDF]

Indian J Ophthalmol
Senthilkumari S, Sharmila R, Ishwarya M, Naresh KB.   +3 more
europepmc   +1 more source

Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response. [PDF]

J Vitreoretin Dis
Bello NR, Wang RC, Boss J, Singer M, Hopkins S, Billawala K, Henry CR, Mammo DA.   +7 more
europepmc   +1 more source

Intravitreal injections of corticosteroid and the risk of central serous chorioretinopathy. [PDF]

PLoS One
Song JR, Woo SJ.
europepmc   +1 more source

Radiation-induced maculopathy and fluocinolone acetonide implant. [PDF]

Graefes Arch Clin Exp Ophthalmol
Fricker J, Nahon-Esteve S, Tick S, Nhari M, Chotard G, Nguyen AM, Baillif S, Kodjikian L, Mathis T.   +8 more
europepmc   +1 more source

Beyond Vision: Prospective Real-World Evaluation of Quality-of-Life and Caregiver Burden in Diabetic Macular Edema Treated with Fluocinolone Acetonide (Iluvien^®). [PDF]

Ophthalmol Ther
Alves-Ambrósio J, Teixeira PC, Garcia M, Chibante-Pedro J, Ruão M.   +4 more
europepmc   +1 more source

Therapeutic Outcomes of Anti-VEGF Agents Versus Corticosteroids in Diabetic Macular Edema: A Comparative Review. [PDF]

Int J Mol Sci
Sanaka S, Yu M.
europepmc   +1 more source

Impact of baseline visual acuity, time-in-range and early treatment on functional outcomes in DMO: insights from the IRISS outcomes. [PDF]

Eye (Lond)
Kozak I, Khoramnia R, Taylor SR, Chakravarthy U, ILUVIEN Registry Safety Study (IRISS) Investigators Group.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fluocinolone Acetonide Intravitreal Implants in Vogt-Koyanagi-Harada Disease

Ocular Immunology and Inflammation, 2009
To describe the use of fluocinolone acetonide implants (Retisert) in Vogt-Koyanagi-Harada disease (VKH).Interventional case series.Retrospective review of medical records.Two patients with VKH requiring high-dose systemic corticosteroid therapy to control their inflammation and bilateral serous retinal detachments received bilateral fluocinolone ...
Nisha R Acharya
exaly   +3 more sources